Barclays PLC Biomerica Inc Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.41 - $5.9 $245 - $424	-72 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$5.06 - $8.0 $121,075 - $191,424	-23,928 Reduced 99.7%	72 $0
Q4 2020 Feb 11, 2021	SELL	$4.71 - $7.85 $68,766 - $114,610	-14,600 Reduced 37.82%	24,000 $120,000
Q3 2020 Nov 12, 2020	SELL	$5.86 - $12.04 $67,390 - $138,460	-11,500 Reduced 22.95%	38,600 $267,000
Q2 2020 Aug 12, 2020	BUY	$5.17 - $8.95 $259,017 - $448,394	50,100 New	50,100 $363,000
Q4 2018 Feb 14, 2019	SELL	$1.7 - $3.58 $90 - $189	-53 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.35 - $4.14 $177 - $219	53 New	53 $0

1.79M

53.7K

Ticker BMRA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,427,700
Market Cap $4.3M
Description
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.